Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Ophthalmol ; 18(2): 248-54, 2008.
Article in English | MEDLINE | ID: mdl-18320518

ABSTRACT

PURPOSE: To compare the clinical outcome of stage III proliferative sickle cell retinopathy (PSR) treated by peripheral retinal scatter photocoagulation to natural course disease. METHODS: Long-term follow-up of 101 patients enrolled in a prospective trial of photocoagulation for PSR has been completed. Among 202 eyes of 101 patients enrolled at the University Eye Clinic of Créteil, 73 eyes showed a stage III PSR, which the authors further divided into five new grades (A, B, C, D, E) considering size, hemorrhage, fibrosis, and visible vessels. Grading was based on a three-mirror fundus examination, 360 degrees color photographs, and fluorescein angiography. Mean follow- up was 4 years. RESULTS: Thirty-eight treated eyes and 35 untreated eyes were included in this study. The evolution was not statistically significant between treated and untreated groups concerning flat sea fan <1 MPS disc area (grade A) or elevated sea fan with partial fibrosis (grade C). Progression and regression were compared between the two groups for grade B, resulting statistically significant (p<0.05). Nine complications (13%) were observed, which only occurred in untreated patients with elevated sea fan and hemorrhage (grade B) or complete fibrosed sea fan with well defined vessels (grade E) (p<0.05). CONCLUSIONS: These data suggest that patients with grade A or C new sea fan classification should not be initially treated but observed.


Subject(s)
Hemoglobin SC Disease/surgery , Laser Coagulation , Retinal Neovascularization/classification , Retinal Neovascularization/surgery , Sickle Cell Trait/surgery , Vitreous Hemorrhage/surgery , beta-Thalassemia/surgery , Adolescent , Adult , Disease Progression , Female , Fluorescein Angiography , Follow-Up Studies , Hemoglobin SC Disease/classification , Humans , Male , Middle Aged , Prospective Studies , Sickle Cell Trait/classification , Treatment Outcome , Vitreous Hemorrhage/classification , beta-Thalassemia/classification
SELECTION OF CITATIONS
SEARCH DETAIL
...